Recombinant mouse PQLC1 is optimized for high-yield production in prokaryotic systems. Key parameters include:
Host Strain: E. coli BL21 (DE3) or TB medium for enhanced expression .
Purification: Use of 2% sarkosyl buffer improves yield and purity .
Recombinant mouse PQLC1 is utilized in:
Immunological Studies: ELISA kits detect anti-PQLC1 antibodies in serum .
Structural Analysis: Purified protein enables cryo-EM or X-ray crystallography studies .
Therapeutic Development: Serves as a target for antibodies or small molecules in cancer research .
| Application | Example Tools | Source |
|---|---|---|
| Antibody Development | Polyclonal and monoclonal antibodies | |
| Immune Response Testing | Freund’s adjuvant-based immunization | |
| Assay Kits | CLIA and ELISA kits |
PQLC1 interacts with proteins involved in:
Functional Elucidation: Direct studies on mouse PQLC1’s role in transport or signaling are needed.
Therapeutic Potential: Exploration of PQLC1 as a biomarker or drug target in lysosomal disorders or cancer.
Pqlc1 belongs to the PQ-loop family of proteins characterized by the presence of internal repeats of PQ motifs. While specific research on mouse Pqlc1 is limited, insights can be drawn from studies on related proteins. Similar to PQBP1, which contains a PRD (residues 104-163) with hepta- and di-amino acid repeats, Pqlc1 likely contains structured domains that facilitate specific interactions with other cellular components . Most PQ-loop proteins function as membrane transporters, with Pqlc1 potentially playing roles in lysosomal transport mechanisms.
Pqlc1 shows differential expression patterns across mouse tissues, with notable expression in neuronal tissues, liver, and kidney. Expression analysis techniques such as qRT-PCR and Western blotting can be employed to quantify tissue-specific expression levels. Similar to PQBP1, which is crucial for the development of cognitive functions and hippocampal neurogenesis, Pqlc1 may exhibit tissue-specific functions that correlate with its expression patterns .
For optimal detection of mouse Pqlc1 in tissue samples, researchers should consider:
Western blotting using validated anti-Pqlc1 antibodies (recommended dilution 1:1000)
Immunohistochemistry for tissue localization (use 4% paraformaldehyde fixation)
Mass spectrometry for protein identification and quantification
When isolating the protein, similar approaches to those used for Plk1 purification can be adapted - using affinity chromatography followed by gel-filtration chromatography for optimal purity .
Based on successful protocols for related proteins, the following expression systems are recommended for mouse Pqlc1:
Bacterial Expression System (E. coli):
Use BL21(DE3) strain with pET or pGEX vectors
Induce expression with 0.5 mM IPTG at 18°C for 16-18 hours
Note: May require optimization due to potential membrane protein properties
Insect Cell Expression System (Sf9 or Hi5 cells):
Mammalian Expression System (HEK293 or CHO cells):
Optimal for post-translational modifications
Use pcDNA3.1 vector with CMV promoter
The choice depends on downstream applications, with bacterial systems suitable for structural studies and mammalian systems for functional characterization.
For optimal purification of recombinant mouse Pqlc1:
For His-tagged constructs:
Use Ni²⁺-NTA affinity chromatography with 20 mM imidazole in wash buffer and 250 mM imidazole for elution
Follow with size-exclusion chromatography using Superdex 200 column
For GST-tagged constructs:
Employ glutathione-sepharose with 50 mM Tris-HCl (pH 8.0), 150 mM NaCl
Consider on-column cleavage with PreScission protease
This approach mirrors successful purification strategies used for the PBD domain of other proteins, where GST-fusion proteins are effectively purified and prepared for further analysis .
To characterize the membrane transport function of Pqlc1:
Liposome Reconstitution Assay:
Reconstitute purified Pqlc1 into liposomes
Measure substrate transport using radiolabeled compounds or fluorescent indicators
Cell-Based Transport Assays:
Develop stable cell lines overexpressing Pqlc1
Measure transport of potential substrates using fluorescent reporters
Electrophysiological Methods:
Patch-clamp techniques for real-time monitoring of transport activity
Suitable for ion transport characterization
These methodologies provide complementary approaches to assess transport kinetics, substrate specificity, and regulatory mechanisms.
For investigating Pqlc1 protein interactions:
Co-immunoprecipitation (Co-IP):
Use anti-Pqlc1 antibodies to pull down protein complexes
Identify interaction partners by mass spectrometry
Yeast Two-Hybrid Screening:
Construct Pqlc1 bait plasmids
Screen against mouse cDNA libraries
Proximity Labeling Methods (BioID or APEX):
Tag Pqlc1 with promiscuous biotin ligase
Identify proximal proteins through streptavidin pulldown
Similar to the interaction studies conducted with PQBP1, which revealed interactions with transcription factors and spliceosomal proteins, these approaches can uncover the interaction network of Pqlc1 .
Based on structural analysis of related PQ-loop proteins:
PQ-Loop Motifs:
Typically contain conserved proline and glutamine residues
Form characteristic membrane-spanning domains
Essential for transport function
N-terminal and C-terminal Domains:
May contain regulatory regions
Often sites for post-translational modifications
Similar to how the CTD domain of PQBP1 contains critical motifs like YxxPxxVL that are essential for complex formation with other proteins, specific motifs within Pqlc1 domains likely mediate its functional interactions .
For crystallizing mouse Pqlc1:
Membrane Protein Crystallization Strategies:
Detergent screening (DDM, LMNG, OG) for protein extraction
Lipidic cubic phase (LCP) crystallization
Use of crystallization chaperones (antibody fragments, nanobodies)
Construct Optimization:
Generate truncation constructs removing flexible regions
Surface entropy reduction mutations
Use thermostabilizing mutations
Data Collection Considerations:
Microfocus beamlines for small crystals
Serial crystallography approaches
The crystal structures of protein complexes like the PBD in complex with Cdc25C and Cdc25C-P target peptides provide methodological precedents for successful structural studies .
For CRISPR-Cas9 editing of mouse Pqlc1:
gRNA Design Strategy:
Target early exons for knockout models
Use at least 3 different gRNAs to increase success rate
Verify specificity with off-target prediction tools
Delivery Methods:
Electroporation of ribonucleoprotein complexes for embryos
Lentiviral delivery for cell line modifications
Verification Protocol:
PCR-based genotyping
Sanger sequencing of modified regions
Western blot confirmation of protein loss
These approaches mirror successful mouse model generation strategies used for studying other proteins, which have provided valuable insights into protein function in vivo .
Based on knowledge of related proteins:
Neurological Phenotypes:
Metabolic Consequences:
Potential disruption of lysosomal function
Metabolomics analysis for identifying accumulated substrates
Immune System Effects:
To address challenges in studying Pqlc1 interactions:
Membrane-Compatible Co-IP Methods:
Use crosslinking agents (DSP, formaldehyde)
Optimize detergent conditions (mild detergents like digitonin)
Employ MYTH (Membrane Yeast Two-Hybrid) system
Split-Reporter Systems:
Split-GFP or NanoBiT for monitoring interactions in live cells
Adaptable to membrane protein topology
Computational Predictions:
Use algorithms trained on membrane protein interactions
Validate top predictions experimentally
These approaches can help overcome the typical challenges associated with studying membrane protein interactions.
For accurate interpretation of Pqlc1 localization:
Fixation and Permeabilization Optimization:
Test multiple fixatives (PFA, methanol, glutaraldehyde)
Compare detergents (Triton X-100, saponin, digitonin)
Antibody Validation Controls:
Use Pqlc1 knockout cells as negative controls
Perform peptide competition assays
Compare multiple antibodies targeting different epitopes
Colocalization Analysis Standards:
Use appropriate statistical measures (Pearson's, Manders' coefficients)
Employ subcellular markers for precise compartment identification
Similar to studies of Plk1 localization, which revealed important roles for both the kinase domain and PBD in targeting, comprehensive analysis of Pqlc1 localization requires careful experimental design and controls .
Recent research on protein phase separation provides a framework for investigating Pqlc1:
Assessment Methods for Phase Separation:
In vitro reconstitution with purified proteins
Fluorescence recovery after photobleaching (FRAP)
Fluorescence correlation spectroscopy (FCS)
Domain Analysis for LLPS Propensity:
Identify low complexity domains
Assess intrinsically disordered regions
Similar to findings with PQBP1, which is involved in liquid-liquid phase separation partly mediated by its PRD domain, Pqlc1 may participate in phase separation processes that contribute to its cellular functions .
Emerging technologies for studying Pqlc1 trafficking include:
Live-Cell Super-Resolution Microscopy:
PALM/STORM techniques for nanoscale localization
Lattice light-sheet microscopy for 3D visualization
Optogenetic Control Systems:
Light-inducible protein interactions
Spatiotemporal control of Pqlc1 function
Quantitative Mass Spectrometry Approaches:
SILAC labeling for trafficking kinetics
Proximity labeling for compartment-specific interactome
These methods provide unprecedented resolution for understanding the dynamic behavior of Pqlc1 in cellular contexts.